cannabidiol for epilepsy | |||||
NEWS | |||||
FDA Approves Cannabidiol for Tuberous Sclerosis Complex The drug was approved by the FDA in 2018 for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut ...
| |||||
Epidiolex Now Available in US for Dravet, LGS Patients Age 1 and Older The cannabidiol was found to be efficient and have an acceptable safety profile as add-on anti-epileptic treatment in people with Dravet — at a dose of ...
| |||||
Billion Dollar Cannabidiol Infused Products Market Growing Usage Continues to Skyrocket ... U.S. Food and Drug Administration (FDA) has approved EPIDIOLEX® (cannabidiol) oral solution to treat seizures associated with tuberous sclerosis ...
| |||||
Cannabidiol Market Size to Exceed $22 Bn By 2026 It works in medical circumstances, such as inflammation, pain, sleep, epilepsy, schizophrenia, anorexia and multiple sclerosis. CBD's infused products ...
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |